Precigen Inc. (PGEN) Stock: Dividends & Earnings

Company Overview:

Market Cap: $2.92B

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $2.99 - $8.98

10 Year PGEN Performance Metrics:

Total Return (with DRIP): -71.8% (-11.89% CAGR)

Total Return (no DRIP): -71.8% (-11.89% CAGR)

Share Price: -71.8% (-11.89% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $2,820

Total Return $ (with DRIP): -$7,180

PGEN Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

PGEN Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for PGEN

Based on past 10-year performance, here are PGEN growth metrics:

Share price CAGR of -11.57%
Dividend CAGR of +0%

Using PGEN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	PGEN (DRIP)	PGEN - No DRIP
Current Price	$8.19	$8.19
Start Shares	1,221.00	1,221.00
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	1,221.00	1,221.00
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$2.39	$8.19
Total Dividends	$0	$0
Final Value	$2,923	$10,000

Estimated Future Value + Dividends - PGEN

NOTE: Above numbers are our estimate based on PGEN's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Precigen Inc. (PGEN) had its IPO on , and is traded on NASDAQ stock exchange.

Precigen Inc. is a biopharmaceutical company focused on developing precision medicines for difficult-to-treat diseases. The company applies gene and cell therapy platforms to create targeted programs in immuno-oncology, autoimmune disorders, and infectious diseases. Its work centers on advancing innovative therapeutic candidates and related research tools that support discovery, preclinical development, and clinical development. Precigen also operates through business segments that include biopharmaceutical activities and specialized research-model services, giving it a broad presence across therapeutic development and life-science applications. Headquartered in Germantown, Maryland, Precigen serves as a clinical-stage innovator in the biotechnology sector, with an emphasis on translating proprietary technology platforms into potential treatments for patients with unmet medical needs.

PGEN website: https://precigen.com